Literature DB >> 6793314

Transcutaneous PCO2 monitoring on adult patients in the ICU and the operating room.

K K Tremper, W C Shoemaker, C R Shippy, L S Nolan.   

Abstract

Studies were performed on 44 patients who were monitored continuously with transcutaneous carbon dioxide (PtcCO2) sensors. The patients were monitored intermittently with arterial and mixed venous blood gases and full hemodynamic and oxygen transport data. Twenty of the studies were performed intraoperatively. A total of 411 data sets revealed a correlation coefficient, r, between arterial and transcutaneous PCO2 of 0.80 when the patients were not in low flow shock, i.e., cardiac index (CI) greater than 1.5 L/min x M2. On the basis of these data, the authors have found the normal arterial-transcutaneous carbon dioxide gradient, delta CO2, (delta CO2 = PtcCO2 -- PaCO2) to be 23 +/- 11 torr. The PtcCO2 monitor was found to be a valuable trend monitor of arterial CO2 tensions of adults during adequate cardiac function in the ICU and the operating room. Twenty-four data sets were collected while 3 patients were monitored during severe shock (CI less than 1.5 L/min x M2). PtcCO2 trended inversely with changes in CI during shock and did not follow PaCO2 (r = --0.85). During shock, delta CO2 = 61 %/- 25 torr. The severity of shock could be roughly determined by comparing the PtcCO2 values with arterial CO2 tensions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6793314     DOI: 10.1097/00003246-198110000-00017

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  15 in total

Review 1.  Noninvasive monitoring of peripheral perfusion.

Authors:  Alexandre Lima; Jan Bakker
Journal:  Intensive Care Med       Date:  2005-09-17       Impact factor: 17.440

2.  Transcutaneous estimation of arterial carbon dioxide in intensive care. Which electrode temperature?

Authors:  G Cheriyan; P Helms; F Paky; D Marsden; M C Chiu
Journal:  Arch Dis Child       Date:  1986-07       Impact factor: 3.791

3.  Effects of protriptyline on sleep related disturbances of breathing in restrictive chest wall disease.

Authors:  A K Simonds; R A Parker; M A Branthwaite
Journal:  Thorax       Date:  1986-08       Impact factor: 9.139

4.  Evaluation of PO2 and PCO2 changes during surgical removal of third molars utilizing enflurane anesthesia.

Authors:  R A Kraut; B Rubal; B Bush
Journal:  Anesth Prog       Date:  1985 May-Jun

5.  Transcutaneous arterial carbon dioxide pressure monitoring in critically ill adult patients.

Authors:  Pablo Rodriguez; François Lellouche; Jerome Aboab; Christian Brun Buisson; Laurent Brochard
Journal:  Intensive Care Med       Date:  2006-01-31       Impact factor: 17.440

6.  Comparison of arterial, end-tidal and transcutaneous PCO2 during moderate exercise and external CO2 loading in humans.

Authors:  U Hoffmann; D Essfeld; J Stegemann
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

7.  Noninvasive monitoring of carbon dioxide: a comparison of the partial pressure of transcutaneous and end-tidal carbon dioxide with the partial pressure of arterial carbon dioxide.

Authors:  C Q Phan; K K Tremper; S E Lee; S J Barker
Journal:  J Clin Monit       Date:  1987-07

8.  Factors influencing transcutaneous oxygen and carbon dioxide measurements in adult intensive care patients.

Authors:  W Hasibeder; M Haisjackl; H Sparr; S Klaunzer; C Hörman; N Salak; R Germann; W J Stronegger; J M Hackl
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

9.  Use of end-tidal PCO2 and transcutaneous PCO2 as noninvasive measurement of arterial PCO2 in extubated patients recovering from general anesthesia.

Authors:  B P Kavanagh; A N Sandler; K E Turner; V Wick; S Lawson
Journal:  J Clin Monit       Date:  1992-07

Review 10.  Transcutaneous PCO2 monitoring in critically ill patients: update and perspectives.

Authors:  Arnaud Mari; Hélène Nougue; Joaquim Mateo; Benoît Vallet; Fabrice Vallée
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.